Arthur T Sands

CIK 1134106 · President, CEO · last filed 2026-02-10

Arthur T Sands is a President, CEO who has filed 22 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for NRIX, was dated Feb 10, 2026. Across all open-market trades the lifetime net is −$684.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $440.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$440.1K
Companies
3
Total Filings
22
Lifetime Open-Market Net
-$684.0K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

LEXG price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NRIX President, CEO — $22.35 — $0 8 2026-02-10
LXRX President & CEO 261,946 $1.68 $440.1K $0 12 2014-03-03
LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted Pres & CEO 1 — — -$684.0K 2 2007-03-30

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-10 NRIX Grant (A) — $0 EDGAR
2025-02-13 NRIX Grant (A) — $0 EDGAR
2024-02-15 NRIX Grant (A) — $0 EDGAR
2023-02-15 NRIX Grant (A) — $0 EDGAR
2022-08-10 NRIX Grant (A) — $0 EDGAR
2022-01-21 NRIX Grant (A) — $0 EDGAR
2021-02-12 NRIX Grant (A) — $0 EDGAR
2020-10-23 NRIX Grant (A) — $0 EDGAR
2014-03-03 LXRX Mixed +78,459 -$57.2K EDGAR
2013-03-01 LXRX Mixed +53,216 -$39.7K EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.